GeneDx Holdings Corp. (WGS)

GeneDx Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,848	2,111	71	102	1,076	20,163
Market Cap Growth	78.68%	2866.28%	-30.24%	-90.52%	-94.66%	-
Enterprise Value	3,898	2,111	31	-11	648	20,051
Last Close Price	135.94	76.86	2.75	8.71	147.18	364.32
Forward PE	448.20	190.96	-	-	-	-
PS Ratio	9.57	6.91	0.35	0.44	5.07	112.44
PB Ratio	13.44	8.61	0.31	0.40	2.77	4595.00
P/TBV Ratio	36.87	24.37	1.29	1.52	2.77	-
EV/Sales Ratio	9.69	6.91	0.15	-	3.06	111.81
Debt / Equity Ratio	0.39	0.47	0.52	0.30	0.03	10.26
Debt / EBITDA Ratio	2.72	17.38	-	-	-	-
Asset Turnover	0.89	0.73	0.45	0.45	0.53	0.79
Inventory Turnover	11.44	11.43	10.34	11.10	7.83	7.61
Quick Ratio	2.47	3.26	2.77	1.17	4.22	1.91
Current Ratio	2.71	3.61	3.10	1.47	4.77	2.37
Return on Equity (ROE)	0.84%	-22.10%	-72.97%	-171.07%	-125.04%	-363.49%
Return on Assets (ROA)	1.62%	-3.20%	-22.72%	-54.72%	-69.21%	-61.04%
Return on Capital (ROIC)	2.01%	-3.79%	-30.48%	-78.35%	-124.34%	-137.09%
Return on Capital Employed (ROCE)	2.90%	-5.90%	-45.90%	-132.00%	-98.50%	-124.80%
Earnings Yield	0.05%	-2.48%	-246.93%	-538.02%	-22.80%	-1.20%
FCF Yield	0.39%	-1.61%	-260.46%	-319.80%	-18.57%	-0.58%
Buyback Yield / Dilution	-7.19%	-10.61%	-137.49%	-212.57%	-	-

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q